A SERS biosensor based on black phosphorus nanosheets and its preparation method and application
The sandwich-structured SERS biosensor constructed using black phosphorus nanosheets and magnetic molybdenum disulfide nanoflowers solves the problems of complex fabrication and poor biocompatibility of traditional SERS-based immunosensors, enabling efficient and cyclic detection of tumor markers.
Patent Information
- Application Number
- CN202211114922.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-09-14
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2042-09-14
AI Technical Summary
Existing SERS-based immunosensors have complex fabrication processes, expensive raw materials, and poor biocompatibility. Photoexcitation of precious metals can cause denaturation of biomolecules, affecting detection performance.
Using black phosphorus nanosheets as an immune substrate, and combining them with magnetic molybdenum disulfide nanoflowers to prepare immune probes, forming a sandwich structure, a simple and inexpensive SERS biosensor is prepared by linking antibodies to the antigen to be tested on the black phosphorus nanosheets and Raman-labeled antibodies on the magnetic molybdenum disulfide nanoflowers.
It achieves good biocompatibility and chemical enhancement effect, significantly amplifies Raman signal, solves the problem of biomolecular denaturation in traditional sensors, and has excellent photocatalytic performance and recyclability.
Smart Images

Figure CN115453122B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of nano-biotechnology, and in particular to a SERS biosensor based on black phosphorus nanosheets and a preparation method and application thereof. Background Art
[0002] Surface enhanced Raman scattering (SERS) technology stands out among the existing cancer immunoassay methods due to its high detection sensitivity, stable signal output and simple operation process.
[0003] In the prior art, precious metal nanoparticles such as Au and Ag are mainly used to prepare SERS-based immunosensors. The immunosensor substrate of this type of SERS-based immunosensor is composed of a three-dimensional porous silver grown by the assistance of a porous gold substrate prepared by electrodeposition, and a gold film is sprayed on the surface of the silver layer by an ion sputtering coating method to protect the silver layer from oxidation. The preparation process of the immunosensor is complex and difficult to operate. The raw materials used are expensive, and the prepared substrate also has defects such as poor biocompatibility and poor detection effect, which is not conducive to the development and application of SERS-based immunosensors. Moreover, due to the presence of precious metals, the electromagnetic hot spots of the precious metals will produce local thermal effects under light excitation, which will denature biological molecules or proteins and coagulate nearby tissues, affecting the detection effect of the SERS-based immunosensor.
[0004] To this end, the present invention provides a SERS biosensor based on black phosphorus nanosheets and a preparation method and application thereof. Summary of the invention
[0005] In order to solve the above-mentioned deficiencies in the prior art, the present invention provides a SERS biosensor based on black phosphorus nanosheets and a preparation method and application thereof.
[0006] The SERS biosensor based on black phosphorus nanosheets and its preparation method and application are realized by the following technical solutions:
[0007] The first object of the present invention is to provide a SERS biosensor based on black phosphorus nanosheets, which is composed of an immune probe, an immune substrate and an antigen to be detected;
[0008] The immune probe is obtained by linking the antibody corresponding to the antigen to be detected on the magnetic molybdenum disulfide nanoflower;
[0009] The immune substrate is obtained by linking the antibody corresponding to the antigen to be tested on the black phosphorus nanosheet;
[0010] The antigen to be detected specifically binds to the immune probe and the immune substrate to form a sandwich structure.
[0011] Furthermore, the diameter of the magnetic molybdenum disulfide nanoflower is 200-1000nm; the diameter of the black phosphorus nanosheet is 200-5000nm.
[0012] Furthermore, the antigen to be detected is any one of PSA tumor marker, CA72-4 tumor marker, CA19-9, CA50 and ferritin.
[0013] Furthermore, the preparation method of the magnetic nano-molybdenum disulfide is as follows:
[0014] The molybdate, the sulfur source and the ferrosoferric oxide are uniformly dispersed in a water solvent, and subjected to a hydrothermal reaction at a temperature of 180 to 220° C. for 6 to 12 hours. After cooling to room temperature, the mixture is washed and dried to obtain magnetic nano-molybdenum disulfide.
[0015] The molybdate is sodium molybdate or ammonium molybdate;
[0016] The sulfur source is thioacetamide or thiourea;
[0017] The molar ratio of the molybdate to the sulfur source and ferrosoferric oxide is 2.5-5:5-11:0.25-0.9;
[0018] The usage ratio of the molybdate to the solvent B is 0.15-0.2 mol:1L.
[0019] Furthermore, the immune probe is obtained by the following steps:
[0020] The magnetic molybdenum disulfide nanoflowers are labeled with Raman molecules to obtain the magnetic molybdenum disulfide nanoflowers labeled with Raman molecules; the antibodies corresponding to the antigen to be detected are linked to the magnetic molybdenum disulfide nanoflowers labeled with Raman molecules, and then the non-specific adsorption sites on the surface of the magnetic molybdenum disulfide nanoflowers are blocked with a blocking agent A to obtain an immune probe;
[0021] The Raman molecule is any one of rhodamine R6G, methylene blue, 4-mercaptobenzoic acid, and 2-naphthalenethiol;
[0022] The blocking agent A is any one of bovine serum albumin, casein and gelatin.
[0023] Furthermore, the immune substrate is obtained by the following steps:
[0024] The antibody corresponding to the antigen to be tested is linked to the black phosphorus nanosheet, and the non-specific adsorption sites on the black phosphorus nanosheet are blocked by a blocking agent B to obtain a black phosphorus nanosheet immune substrate;
[0025] The blocking agent B is any one of bovine serum albumin, casein and gelatin.
[0026] The second object of the present invention is to provide a method for preparing the above-mentioned SERS biosensor, comprising the following steps:
[0027] Step 1, uniformly dispersing the immune substrate in a phosphate buffer solution to obtain an immune substrate solution;
[0028] Step 2, adding the antigen to be tested to the immune substrate solution, performing incubation treatment A to obtain a mixed solution A, then adding the immune probe to the mixed solution A, performing incubation treatment B after mixing, and obtaining a SERS biosensor.
[0029] Furthermore, the immune substrate is in the form of a solution, and its concentration is 3 to 7 mg / mL;
[0030] The volume ratio of the immune substrate to the phosphate buffer solution is 0.5 to 1.5:1;
[0031] The concentration of the antigen to be tested is 5 to 20 μg / mL, and the volume ratio of the antigen to be tested to the immune substrate solution is 1 to 3:100;
[0032] The immunoprobe is in the form of a solution, and its concentration is 5 to 15 mg / mL;
[0033] The volume ratio of the immune probe to the mixed solution A is 0.5-1.5:1.
[0034] Further, the incubation temperature of the incubation treatment A is 4°C and the incubation time is 12h;
[0035] The incubation temperature of the incubation treatment B is 37° C. and the incubation time is 1 hour.
[0036] The third object of the present invention is to provide an application of the above-mentioned SERS biosensor in the detection of tumor markers.
[0037] Compared with the prior art, the present invention has the following beneficial effects:
[0038] The SERS biosensor of the present invention is composed of an immune probe, an immune substrate and an antigen to be detected; the immune probe is obtained by linking an antibody corresponding to the antigen to be detected on a magnetic molybdenum disulfide nanoflower; the immune substrate uses a black phosphorus nanosheet as a matrix, and the antibody corresponding to the antigen to be detected is linked thereon to form an immune substrate. The preparation process is simple and easy to operate, and the price of the raw materials is not high. In addition, its band gap is within the range of 0.5-2eV, and it has a very matching staggered energy band structure with the magnetic molybdenum disulfide nanoflower on the immune probe, which greatly promotes the chemical enhancement effect and significantly amplifies the Raman signal of the labeled molecule, so that the SERS immune sensor of the present invention has good biocompatibility, and well solves the problems that traditional noble metal sensors can cause biomolecules or proteins to denature and nearby tissues to coagulate.
[0039] The two semiconductors, molybdenum disulfide and black phosphorus, in the immunosensor of the present invention have high carrier mobility, and the immunosensor of the present invention also has excellent photocatalytic performance, which is conducive to the rapid degradation of antigens, antibodies and Raman molecules. At the same time, the present invention can not only improve the morphology of nano molybdenum disulfide, enhance its adsorption effect on the substance to be measured, and improve its detection effect by adding a certain amount of ferroferric oxide during the preparation process of molybdenum disulfide, but also facilitate the use of an external magnet to achieve effective separation and dual-circulation use of the immune probe and the immune substrate.
[0040] The SERS immunosensor prepared by the present invention is stored in a phosphate buffer solution for subsequent SERS detection. After the SERS detection is completed, the immune structure is irradiated with a visible light simulator, and Raman molecules, antigens and antibodies can be degraded based on the good photocatalytic activity of molybdenum disulfide nanoflowers and black phosphorus nanosheets. Finally, a magnet is used to separate and collect the immune probe and the immune substrate for subsequent tumor marker detection. This is repeated to achieve cyclic immune detection.
[0041] The SERS biosensor based on black phosphorus nanosheets prepared in the present invention can be used for ultrasensitive and cyclic detection of tumor markers due to its strong SERS enhancement, excellent biocompatibility and photocatalytic activity. BRIEF DESCRIPTION OF THE DRAWINGS
[0042] Figure 1 This is a scanning electron microscope photo of the immune probe prepared in Example 1;
[0043] Figure 2 This is a scanning electron microscope photo of the immune probe prepared in Example 2;
[0044] Figure 3 This is a scanning electron microscope photo of the flower immune probe prepared in Example 3;
[0045] Figure 4This is a scanning electron micrograph of the immune substrate prepared in Example 1;
[0046] Figure 5 This is a scanning electron micrograph of the immune substrate prepared in Example 2;
[0047] Figure 6 This is a scanning electron micrograph of the immune substrate prepared in Example 3;
[0048] Figure 7 A scanning electron microscope photograph of the SERS biosensor prepared in Example 1;
[0049] Figure 8 The Raman detection results of the flower immune probe and immune substrate prepared in Example 1 for rhodamine 6G;
[0050] Fig. 9 The Raman detection result of the immune probe prepared in Example 2 on rhodamine 6G;
[0051] Fig.10 The Raman detection result of Rhodamine 6G by the nanoflower immune probe prepared in Example 3;
[0052] Fig.11 This is the Raman detection result of ferritin in serum by the SERS biosensor prepared in Example 1. DETAILED DESCRIPTION
[0053] The technical solutions in the embodiments of the present invention will be described clearly and completely below in conjunction with the accompanying drawings in the embodiments of the present invention.
[0054] Example 1
[0055] This embodiment provides a SERS biosensor based on black phosphorus nanosheets, which is composed of an immune probe, an immune substrate and an antigen to be detected;
[0056] The immune probe is obtained by linking the antibody corresponding to the antigen to be detected on the magnetic molybdenum disulfide nanoflower;
[0057] The immune substrate is obtained by linking the antibody corresponding to the antigen to be tested on the black phosphorus nanosheet;
[0058] The antigen to be detected specifically binds to the immune probe and the immune substrate to form a sandwich structure.
[0059] The antigen to be tested in the present invention can be selected according to actual needs, such as: to study prostate-related diseases, PSA tumor markers can be selected; to detect gastric cancer, CA72-4 tumor markers can be selected; to detect intestinal cancer, CA19-9 can be selected; to detect digestive system diseases, CA50 can be selected. Ferritin is a shell-like carrier protein that plays a role in proliferation, angiogenesis, immunosuppression and iron delivery. Many cancer patients have high levels of ferritin in their serum, which is very relevant to invasive diseases and poor clinical outcomes. In addition, ferritin is highly expressed in tumor-associated macrophages, which have been considered to play a key role in tumor detection progress and treatment resistance in recent years. These characteristics indicate that ferritin may become an attractive target for cancer treatment. Therefore, this embodiment selects ferritin antigen as a detection object, and the SERS biosensor of this embodiment is composed of an immune probe, an immune substrate and a ferritin antigen, and the immune probe is obtained by linking ferritin antibodies on magnetic molybdenum disulfide nanoflowers; the immune substrate is obtained by linking ferritin antibodies on black phosphorus nanosheets.
[0060] The preparation method of the SERS biosensor based on black phosphorus nanosheets in this embodiment is as follows:
[0061] Step 1, uniformly dispersing the immune substrate in a phosphate buffer solution to obtain an immune substrate solution;
[0062] It should be noted that the present invention uses phosphate buffer solution as a solvent, which can not only dissolve and protect the immune substrate but also has salt balance and an adjustable suitable pH buffering effect, which can ensure that the biologically active substances maintain their complete characteristics.
[0063] The present invention does not limit the specific preparation method of the immune substrate, as long as the ferritin antibody can be linked to the black phosphorus nanosheet, so that the prepared immune substrate can carry out a specific immune reaction between the ferritin antibody and the ferritin antigen thereon. In this embodiment, according to the dosage ratio of 5 mg: 1 mL, 1 mL of 5 mg / L immune substrate is dispersed in 1 mL of phosphate buffer solution to obtain an immune substrate solution.
[0064] Step 2, adding ferritin antigen to the immune substrate solution, performing incubation treatment A to obtain a mixed solution A, then adding the immune probe to the mixed solution A, mixing and performing incubation treatment B to obtain a SERS biosensor;
[0065] It should be noted that the present invention does not limit the specific process of incubation treatment A, as long as the ferritin antibodies linked to the black scale nanosheets in the immune substrate solution can fully capture the ferritin antigen, and then facilitate the formation of a SERS biosensor with a sandwich immune structure with the subsequently added immune probe. Optionally, in this embodiment, 20 μL of 5 μg / mL ferritin antigen is weighed, added to the above 1 mL of immune substrate solution, and incubated at an incubation temperature of 37 ° C for 2 hours to obtain a mixed solution A. The present invention does not limit the specific process of incubation treatment B, as long as the ferritin antibodies linked to the magnetic molybdenum disulfide nanoflowers in the immune probe can be specifically immune-bound to the ferritin antigen specifically immune-bound on the immune substrate to form a SERS biosensor with a sandwich immune structure. Optionally, in this embodiment, 3 to 9 mg of immune probe is added to the above mixed solution A, and then cultured at 37 ° C for 2 hours.
[0066] It should also be noted that in order to avoid insufficient binding of the ferritin antigen to the immune substrate, so that the subsequently added immune probe cannot effectively bind to the ferritin antigen specifically immune-bound on the immune substrate through specific immune binding, this embodiment also uses phosphate buffer solution to wash and remove uncaptured antigens before adding the immune probe.
[0067] In this embodiment, it should be noted that the immune substrate is prepared by the following steps:
[0068] S1, Preparation of black phosphorus nanosheets
[0069] The black phosphorus powder is uniformly dispersed in solvent A, and the oxygen dissolved in the solution is discharged, followed by ultrasonic treatment to peel off the black phosphorus nanosheets, thereby obtaining a black phosphorus nanosheet solution;
[0070] The solvent A used can be selected from any one of N-methylpyrrolidone, N,N-dimethylformamide, cumene peroxide and water, as long as the solvent molecules can destroy the van der Waals force between the blocky black phosphorus layers under the assistance of ultrasound, thereby obtaining a large amount of stably dispersed few-layer black phosphorus nanosheet solution. In this embodiment, N-methylpyrrolidone is preferably used as the solvent, which is not only conducive to large-scale ultrasonic few-layer black phosphorus nanosheet dispersion, but also can prevent the oxidation of black phosphorus during the stripping process.
[0071] The present invention does not limit the specific method of discharging the oxygen dissolved in the solution, as long as the oxygen dissolved in the solution can be discharged. Optionally, in this embodiment, argon bubbling is used to discharge the oxygen dissolved in the liquid. The specific operation is: insert the rubber tube connected to the argon cylinder into the large test tube containing the black phosphorus solution, and use inert gas argon bubbling to deoxygenate. The flow rate of argon is 80mL / h, and the bubbling time is 1h. When the bubbles are uniform and stable, it can be considered that the oxygen is completely discharged.
[0072] The present invention does not limit the specific process of S1 ultrasonic treatment, as long as it can achieve the black phosphorus nanosheets peeled off from the black phosphorus grinding powder and obtain a black phosphorus nanosheet solution with uniform components. Optionally, in this embodiment, 40 mg of black phosphorus grinding powder is added to 40 mL of N-methylpyrrolidone at a dosage ratio of 1 mg: 1 mL, and an ultrasonic power of 300 W is used at a temperature of 4 to 6 ° C for 4 hours, followed by centrifugation at a speed of 2500 r / min for 20 minutes to remove the unpeeled black phosphorus crystals, and the obtained supernatant is used as a black phosphorus nanosheet solution with uniform components.
[0073] S2, Attaching ferritin antibody to black phosphorus nanosheets
[0074] After mixing the ferritin antibody with the black phosphorus nanosheet solution, an incubation treatment C is performed to obtain a mixed solution B; bovine serum albumin is added to the mixed solution B to block nonspecific adsorption sites on the black phosphorus nanosheet to obtain a black phosphorus nanosheet immune substrate;
[0075] It should be noted that the present invention does not limit the specific method of incubation treatment C, as long as the ferritin antibody can be linked to the black phosphorus nanosheet to form an immune substrate. Optionally, in this embodiment, 20 μL of ferritin antibody with a concentration of 0.2 mg / mL is weighed and added to 1 mL of the above black phosphorus nanosheet solution, mixed and cultured at a culture temperature of 4°C for 12 hours to obtain a black phosphorus nanosheet solution after culture treatment.
[0076] In order to block the non-specific adsorption sites on the black phosphorus nanosheets, the present invention first uses a phosphate buffer solution to wash the product in the black phosphorus nanosheet solution after the culture treatment, and when washing the black phosphorus nanosheets linked to the antibody, the black phosphorus nanosheet solution is first separated into solid and liquid by centrifugation, and the solution is removed to obtain a black phosphorus nanosheet solid, and then the black phosphorus nanosheet solid is washed 2-3 times with a phosphate buffer solution until the washing solution is uniform and clear, and finally dispersed in 1mL of phosphate buffer solution. Subsequently, 3wt% bovine serum albumin is added to the washed black phosphorus nanosheet solution, incubated at 37°C for 1h, and then centrifuged at a centrifugal rate of 2500r / min, and then washed with a phosphate buffer solution to remove excess bovine serum albumin to block the non-specific adsorption sites and obtain a black phosphorus nanosheet immune substrate.
[0077] In this embodiment, it should be noted that the immune probe is prepared by the following steps:
[0078] S1, linking ferritin antibody on magnetic MoS2 nanoflowers:
[0079] The magnetic molybdenum disulfide nanoflowers were labeled with Raman molecules, and then ferritin antibodies were added for incubation treatment D to obtain a mixed solution C;
[0080] It should be noted that due to the complexity of the biological components in serum and its small scattering cross section, it is very difficult to directly perform specific detection of cancer markers based on SERS technology. The present invention adopts a Raman molecule labeling indirect detection strategy and develops a non-metallic sandwich immunosensor for detecting ferritin in serum. The above Raman molecule can be selected from any one of rhodamine R6G, methylene blue, 4-mercaptobenzoic acid, and 2-naphthalenethiol. The inventors consider that rhodamine R6G is very compatible with the spectrometer with an excitation wavelength of 532nm used in the present invention. In order to obtain more accurate detection results, rhodamine R6G is the best choice for the SERS label of the present invention, and the role of rhodamine R6G in this embodiment is to serve as a SERS label of the immunosensor, and its Raman signal intensity indirectly reflects the content of ferritin.
[0081] The present invention does not limit the specific method of labeling magnetic molybdenum disulfide nanoflowers with rhodamine R6G, as long as labeling can be achieved. Since the immune reaction needs to be carried out in a solution, the present invention labels magnetic molybdenum disulfide nanoflowers in a solution state. Optionally, in this embodiment, 20 mg of magnetic molybdenum disulfide nanoflowers are weighed and evenly dispersed in 1 mL of deionized water to obtain a magnetic molybdenum disulfide nanoflower solution; then, 200 μL of a 10% concentration of argon is added to the magnetic molybdenum disulfide nanoflower solution. -2mol / L of Rhodamine R6G, and the labeling treatment was carried out by stirring at room temperature, with a stirring rate of 200r / min and a stirring time of 12h.
[0082] In order to prevent the excess ferritin antibodies added by incubation treatment D from affecting subsequent treatment, the present invention also performs the following treatment on the mixed solution C: a magnet is placed close to the test tube containing the magnetic molybdenum disulfide nanoflower immunoprobe solution. Due to the mutual attraction between the ferric oxide attached to the molybdenum disulfide nanoflower and the external magnet, the successfully constructed molybdenum disulfide nanoflower immunoprobe is quickly sucked to the test tube wall close to the magnet. At this time, the solution in the test tube is sucked out with a pipette, and then 4-5 ml of deionized water is added for oscillation and washing, and then the liquid is removed by a magnet and a pipette. The process is repeated 5-6 times until the excess ferritin is completely removed and the solution is transparent and clear.
[0083] S2, blocking the non-specific adsorption sites on the surface of magnetic MoS2 nanoflowers:
[0084] Adding bovine serum albumin to the mixed solution C for incubation treatment E to seal the exposed positions on the surface of the magnetic molybdenum disulfide nanoflowers to obtain magnetic molybdenum disulfide nanoflower immune probes;
[0085] In order to facilitate the subsequent treatment of the labeled magnetic molybdenum disulfide nanoflowers, the present invention also cleans the magnetic molybdenum disulfide nanoflowers labeled with rhodamine 6G by magnetic collection before incubation treatment E, and the product obtained after cleaning is evenly dispersed in 1 mL of phosphate buffer solution to obtain a magnetic molybdenum disulfide nanoflower solution, and then ferritin antibodies are added to the magnetic molybdenum disulfide nanoflower solution for incubation treatment. Among them, the magnetic collection is specifically carried out in the following steps: a rubidium neodymium iron boron rectangular strong magnet (50*30*10 mm) is used for cleaning treatment. The magnetic molybdenum disulfide nanoflowers are labeled with rhodamine 6G to prepare immune probes. For the accuracy of immune detection, excess rhodamine 6G molecules need to be cleaned and removed. The specific implementation process is as follows: the magnet is placed close to the test tube containing the magnetic molybdenum disulfide nanoflower solution labeled with rhodamine 6G. Due to the mutual attraction between the ferroferric oxide attached to the molybdenum disulfide nanoflower and the external magnet, the successfully labeled molybdenum disulfide nanoflowers are quickly sucked to the test tube wall close to the magnet. At this time, use a pipette to suck out the solution in the test tube, then add 4-5 ml of deionized water and shake to wash, then use a magnet and pipette to remove the liquid, and repeat this process 5-6 times until all the excess Rhodamine 6G molecules are removed and the solution becomes transparent and clear.
[0086] The present invention does not limit the specific method of incubation treatment E, as long as the ferritin antibody can be tightly anchored on the labeled magnetic molybdenum disulfide surface, it is convenient for the subsequent capture of ferritin antigens to form a SERS biosensor. Optionally, in this embodiment, 3wt% bovine serum albumin is added to the magnetic molybdenum disulfide nanoflower solution after removing excess ferritin antibodies to seal the exposed position on the sample surface, and the sample is cultured at a culture temperature of 37°C for 1 hour to obtain a magnetic molybdenum disulfide nanoflower immune probe.
[0087] It should also be noted that the magnetic flower-shaped molybdenum disulfide in this embodiment has a molybdenum disulfide-coated iron oxide structure, and is obtained by the following steps:
[0088] The iron source and the chelating agent are uniformly dispersed in solvent A, and subjected to hydrothermal reaction at a temperature of 180° C. for 1.5 hours to obtain small particles of ferroferric oxide; molybdate, a sulfur source and small particles of ferroferric oxide are uniformly dispersed in solvent B according to a molar ratio of molybdate to sulfur source to ferroferric oxide of 2.5-5:5-11:0.25-0.9, and subjected to hydrothermal reaction at a temperature of 200° C. for 20 hours. After cooling to room temperature, the product is washed 3 times and dried at 80° C. for 8-12 hours to obtain magnetic molybdenum disulfide nanoflowers having a ferroferric oxide-coated molybdenum disulfide structure;
[0089] The present invention does not limit the specific type of the iron source, as long as it can provide Fe, and can be selected from any one of ferric chloride, ferric nitrate, potassium ferrocyanide and ferrous sulfate heptahydrate. Optionally, the present invention uses ferric chloride as the iron source, and weighs 0.54 g for standby use.
[0090] The present invention does not limit the specific type of chelating agent, as long as it can chelate with trivalent iron ions to generate reddish brown ferric hydroxide, and finally generate black ferrosoferric oxide under high temperature and high pressure conditions. The chelating agent of the present invention can be selected from any one of triethanolamine, ethylene glycol and ethylenediamine. Optionally, in the present embodiment, triethanolamine is used as the chelating agent.
[0091] The specific type of the solution A of the present invention can be any type as long as it can form a uniform solution or suspension with the iron source and triethanolamine. Optionally, in this embodiment, deionized water is used as the solvent A.
[0092] The present invention does not limit the dispersion method of the iron source and triethanolamine in solvent A, as long as the iron source and triethanolamine can be evenly dispersed in solvent A. Optionally, the present invention performs dispersion treatment in a stirring manner, and 0.78g of ferric chloride and 4mL of triethanolamine are stirred at a stirring rate of 800r / min for 30min.
[0093] The present invention does not limit the specific type of molybdate, as long as it can provide molybdenum ions, and can be selected from any one of ammonium molybdate, calcium molybdate and sodium molybdate. Optionally, in this embodiment, sodium molybdate is used as the molybdate, and 0.78 g is weighed for standby use.
[0094] The present invention does not limit the specific type of sulfur source, as long as it can provide S, and can be selected from any one of thiourea, thioacetamide, potassium thiocyanate, carbon disulfide and sulfur. Optionally, in this embodiment, thiourea is used as the sulfur source, and 0.6 g is weighed for standby use.
[0095] The specific type of solution B of the present invention can be any type as long as it can form a uniform solution or suspension with molybdate, sulfur source and ferrosoferric oxide. Optionally, in this embodiment, deionized water is used as solvent B, and 40 mL is weighed for standby use.
[0096] The present invention does not limit the dispersion mode of molybdate, sulfur source and ferroferric oxide in solvent B, as long as molybdate, sulfur source and ferroferric oxide can be uniformly dispersed in solvent B. Optionally, the present invention performs dispersion treatment in a stirring manner, and 0.78g of sodium molybdate, 0.6g of thiourea and 0.13g of the above-mentioned ferroferric oxide small particles are placed in 40mL of deionized water and stirred at a stirring rate of 800r / min for 1h.
[0097] Example 2
[0098] This embodiment provides a SERS biosensor based on black phosphorus nanosheets, and the preparation method of the SERS biosensor based on black phosphorus nanosheets in this embodiment is different from that in Embodiment 1 only in that:
[0099] In this embodiment, when preparing magnetic molybdenum disulfide nanoflowers:
[0100] The amount of ferric chloride used is 0.78 g, the amount of sodium molybdate used is 0.52 g, the amount of thiourea used is 0.4 g, and the amount of ferrosoferric oxide small particles is 0.195 g.
[0101] In this embodiment, when preparing the immune probe:
[0102] The amount of rhodamine 6G used was 100 μL, and the amount of magnetic molybdenum disulfide nanoflowers used was 0.5 mL;
[0103] The amount of ferritin antibody used is 10 μL.
[0104] In this embodiment, when preparing the immune substrate:
[0105] The amount of ferritin antibody used is 10 μL; the amount of black phosphorus nanosheet solution used is 0.5 mL.
[0106] In this embodiment, when preparing the SERS biosensor:
[0107] The amount of ferritin antigen used was 10 μL;
[0108] The dosage of magnetic molybdenum disulfide nanoflower immunoprobe is 0.5 mL.
[0109] Example 3
[0110] This embodiment provides a SERS biosensor based on black phosphorus nanosheets, and the preparation method of the SERS biosensor based on black phosphorus nanosheets in this embodiment is different from that in Example 1 only in that:
[0111] In this embodiment, when preparing magnetic molybdenum disulfide nanoflowers:
[0112] The amount of ferric chloride used is 0.27 g, and the amount of triethanolamine used is 2 mL;
[0113] The dosage of sodium molybdate is 1.04g, the dosage of thiourea is 0.8g, and the dosage of ferrosoferric oxide small particles is 0.065g.
[0114] In this embodiment, when preparing the immune probe:
[0115] The amount of rhodamine 6G used was 300 μL, and the amount of magnetic molybdenum disulfide nanoflowers used was 1.5 mL;
[0116] The amount of ferritin antibody used is 30 μL.
[0117] In this embodiment, when preparing the immune substrate:
[0118] The amount of ferritin antibody used is 30 μL; the amount of black phosphorus nanosheet solution used is 1.5 mL.
[0119] In this embodiment, when preparing the SERS biosensor:
[0120] The amount of ferritin antigen used was 30 μL;
[0121] The dosage of magnetic molybdenum disulfide nanoflower immunoprobe is 1.5 mL.
[0122] Example 4
[0123] This embodiment provides a SERS biosensor based on black phosphorus nanosheets, and the preparation method thereof is different from that of embodiment 1 only in that:
[0124] In this embodiment, when preparing ferrosoferric oxide, ferrous sulfate heptahydrate is used as an iron source and sodium citrate is used as a stabilizer;
[0125] In the present embodiment, when preparing magnetic nano-molybdenum disulfide, ammonium molybdate is used as molybdate, thioacetamide is used as sulfur source, and the molar ratio of molybdate to sulfur source and ferrosoferric oxide is 2.5:5:0.25;
[0126] The temperature of the hydrothermal reaction was 180 °C and the reaction time was 12 h;
[0127] In this embodiment, when preparing the immune probe:
[0128] Methylene blue was used as the Raman molecule.
[0129] Example 5
[0130] This embodiment provides a SERS biosensor based on black phosphorus nanosheets, and the preparation method thereof is different from that of embodiment 1 only in that:
[0131] In this embodiment, when preparing ferroferric oxide: potassium ferrocyanide is used as the iron source and sodium citrate is used as the chelating agent;
[0132] In the present embodiment, when preparing magnetic nano-molybdenum disulfide, ammonium molybdate is used as molybdate, thioacetamide is used as sulfur source, and the molar ratio of molybdate to sulfur source and ferrosoferric oxide is 5:11:0.9;
[0133] The temperature of the hydrothermal reaction was 220°C and the reaction time was 6 h.
[0134] Experimental part
[0135] (I) Scanning electron microscope test
[0136] The present invention respectively performs scanning electron microscope tests on the magnetic molybdenum disulfide nanoflower immune probes and black phosphorus nanosheet immune substrates prepared in Examples 1, 2 and 3, and the SERS biosensor prepared in Example 1, and the results are as follows: Figure 1-7 shown.
[0137] Figure 1 This is a scanning electron microscope photo of the magnetic molybdenum disulfide nanoflower immunoprobe prepared in Example 1. It can be seen that in the magnetic molybdenum disulfide nanoflower immunoprobe prepared in Example 1, molybdenum disulfide is self-assembled by two-dimensional nanosheets with spiked edges. At the same time, it is also observed that tiny ferroferric oxide particles are randomly decorated on the surface of the petals.
[0138] Figure 2 This is a scanning electron microscope photograph of the magnetic molybdenum disulfide nanoflower immune probe prepared in Example 2. It can be seen that in the magnetic molybdenum disulfide nanoflower immune probe prepared in Example 2, a large amount of ferrosoferric oxide particles cover the surface of the molybdenum disulfide nanoflower.
[0139] Figure 3This is a scanning electron microscope photo of the magnetic molybdenum disulfide nanoflower immune probe prepared in Example 3. It can be seen that in the magnetic molybdenum disulfide nanoflower immune probe prepared in Example 3, molybdenum disulfide is self-assembled by two-dimensional nanosheets with spiked edges. At the same time, a very small amount of ferroferric oxide particles covers the surface of molybdenum disulfide.
[0140] Figure 4 This is a scanning electron microscope photograph of the black phosphorus nanosheet immunogenic substrate prepared in Example 1. It can be seen that in the immunogenic substrate prepared in Example 1, the surface of the black phosphorus nanosheet is smooth and flat, providing abundant attachment sites for biological molecules.
[0141] Figure 5 This is a scanning electron microscope photograph of the black phosphorus nanosheet immunogenic substrate prepared in Example 2. It can be seen that in the immunogenic substrate prepared in Example 2, the black phosphorus nanosheets have a large lateral size and a block structure.
[0142] Figure 6 This is a scanning electron microscope photograph of the black phosphorus nanosheet immunogenic substrate prepared in Example 3. It can be seen that in the immunogenic substrate prepared in Example 3, the black phosphorus nanosheets have a small lateral size and a thin sheet structure.
[0143] Figure 7 This is a scanning electron microscope photograph of the SERS biosensor prepared in Example 1. It can be seen that in the SERS biosensor prepared in Example 1, due to the specific reaction of the ferritin antigen and the antibody, the magnetic molybdenum disulfide nanoflowers and the black phosphorus nanosheets are tightly combined together.
[0144] (II) Raman test
[0145] The invention respectively carried out Raman detection of rhodamine 6G on the magnetic molybdenum disulfide nanoflower immune probes and black phosphorus nanosheet immune substrates prepared in Examples 1, 2 and 3, and the SERS biosensor prepared in Example 1, and the tests were as follows: Figure 8-11 shown.
[0146] The Raman detection method of the present invention is in accordance with. The instrument is: 532nm Raman spectrometer (QE Pro, Ocean Optics), the laser power is 1mW, and the integration time is 10s. According to Reusable dual-functional SERS sensor based on old nanoflowers-modified red phosphorus nanoplates for ultrasensitive immunoassay and degradation of CA19-9 (DOI: 10.1016 / j.bios.2022.114148) and Intrinsic Raman signal of polymer matrix induced quantitative multiphase SERS analysis based on stretched PDMS film with anchoredAg nanoparticles / Aunanowires (DOI: 10.1016 / j.cej.2019.122710) and other papers for testing.
[0147] Figure 8 The Raman detection results of the magnetic MoS2 nanoflower immune probe and the black phosphorus nanosheet immune substrate prepared in Example 1 for rhodamine 6G. It can be seen that the magnetic MoS2 nanoflower immune probe and the black phosphorus nanosheet immune substrate prepared in Example 1 have good Raman enhancement effects on rhodamine 6G. -1 The Raman signal intensities at 8295 and 5493 respectively.
[0148] Fig. 9 The Raman detection results of the magnetic MoS2 nanoflower immune probe prepared in Example 2 for Rhodamine 6G show that the magnetic MoS2 nanoflower immune probe prepared in Example 2 has a good Raman enhancement effect on Rhodamine 6G. -1 The Raman signal intensity at reached 3706.
[0149] Fig.10 The Raman detection results of the magnetic MoS2 nanoflower immunoprobe prepared in Example 3 for Rhodamine 6G show that the magnetic MoS2 nanoflower immunoprobe prepared in Example 3 has a SERS enhancement effect on Rhodamine 6G. -1 The Raman signal intensity at 6483.
[0150] Fig.11This is the Raman detection result of the SERS biosensor prepared in Example 1 on ferritin in serum. It can be seen that the SERS biosensor prepared in Example 1 can achieve ultrasensitive detection of ferritin in serum.
[0151] Obviously, the above embodiments are only some embodiments of the present invention, not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
Claims
1. A SERS biosensor based on black phosphorus nanosheets, characterized in that: It is composed of immune probe, immune substrate and antigen to be detected; The immune probe is obtained by linking the antibody corresponding to the antigen to be detected on the magnetic molybdenum disulfide nanoflower; The immune substrate is obtained by linking the antibody corresponding to the antigen to be tested on the black phosphorus nanosheet; The antigen to be detected specifically binds to the immune probe and the immune substrate to form a sandwich structure; The diameter of the magnetic molybdenum disulfide nanoflower is 200-1000nm; the diameter of the black phosphorus nanosheet is 200-5000nm; The preparation method of the magnetic nano molybdenum disulfide nanoflower is as follows: The molybdate, the sulfur source and the ferroferric oxide are uniformly dispersed in a water solvent, and subjected to a hydrothermal reaction at a temperature of 180 to 220° C. for 6 to 12 hours. After cooling to room temperature, the mixture is washed and dried to obtain magnetic nano-molybdenum disulfide nanoflowers. The molybdate is sodium molybdate or ammonium molybdate; The sulfur source is thioacetamide or thiourea; The molar ratio of the molybdate to the sulfur source and ferrosoferric oxide is 2.5-5:5-11:0.25-0.9; The molybdate and water solvent are used in a ratio of 0.15 to 0.2 mol:1L; The immunoprobe is obtained by the following steps: The magnetic molybdenum disulfide nanoflowers are labeled with Raman molecules to obtain the magnetic molybdenum disulfide nanoflowers labeled with Raman molecules; the antibodies corresponding to the antigen to be detected are linked to the magnetic molybdenum disulfide nanoflowers labeled with Raman molecules, and then the non-specific adsorption sites on the surface of the magnetic molybdenum disulfide nanoflowers are blocked with a blocking agent A to obtain an immune probe; The Raman molecule is any one of rhodamine R6G, methylene blue, 4-mercaptobenzoic acid, and 2-naphthalenethiol; The blocking agent A is any one of bovine serum albumin, casein and gelatin.
2. The SERS biosensor according to claim 1, wherein The antigen to be detected is any one of PSA tumor marker, CA72-4 tumor marker, CA19-9, CA50 and ferritin.
3. The SERS biosensor according to claim 1, wherein: The immune substrate is obtained by the following steps: The antibody corresponding to the antigen to be tested is linked to the black phosphorus nanosheet, and the non-specific adsorption sites on the black phosphorus nanosheet are blocked by a blocking agent B to obtain a black phosphorus nanosheet immune substrate; The blocking agent B is any one of bovine serum albumin, casein and gelatin.
4. A method for preparing the SERS biosensor according to any one of claims 1 to 3, characterized in that: The following steps are involved: Step 1, uniformly dispersing the immune substrate in a phosphate buffer solution to obtain an immune substrate solution; Step 2, adding the antigen to be tested to the immune substrate solution, performing incubation treatment A to obtain a mixed solution A, then adding the immune probe to the mixed solution A, performing incubation treatment B after mixing, and obtaining a SERS biosensor.
5. The preparation method according to claim 4, characterized in that: The immune substrate is in the form of a solution, and its concentration is 3-7 mg / mL; The volume ratio of the immune substrate to the phosphate buffer solution is 0.5 to 1.5:1; The concentration of the antigen to be tested is 5 to 20 μg / mL, and the volume ratio of the antigen to be tested to the immune substrate solution is 1 to 3:100; The immunoprobe is in the form of a solution, and its concentration is 5 to 15 mg / mL; The volume ratio of the immune probe to the mixed solution A is 0.5-1.5:
1.
6. The preparation method according to claim 4, characterized in that: The incubation temperature of the incubation treatment A is 4°C and the incubation time is 12h; The incubation temperature of the incubation treatment B is 37° C. and the incubation time is 1 hour.
7. Use of the SERS biosensor according to any one of claims 1 to 3 in preparing a tumor marker detection reagent.
